1-Sarcosine–angiotensin II infusion effects on food intake, weight loss, energy expenditure, and skeletal muscle UCP3 gene expression in a rat model

Journal of Cachexia, Sarcopenia and Muscle

Volumn 5, Issue 3, 2014, Pages 239-246

  Cichello, S A ^a,b   Weisinger, R S ^a   Schuijers, J ^a   Jois, M ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

1 Sarcosine angiotensin II; Adipose tissue; Ang II; Angiotensin II; Cachexia; Cardiac cachexia; Energy expenditure; mRNA; Skeletal muscle; UCP; Uncoupling protein; Wasting

Indexed keywords

1 SARCOSINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; SARCOSINE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 3;

ADIPOSE TISSUE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CACHEXIA; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENERGY EXPENDITURE; ENERGY METABOLISM; FECES; FEMALE; FLUID INTAKE; FOOD INTAKE; GENE EXPRESSION; HEART WEIGHT; KIDNEY MASS; LIVER WEIGHT; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; URINARY EXCRETION; WEIGHT REDUCTION;

EID: 84951558819     PISSN: 21905991     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13539-014-0133-2     Document Type: Article

References (37)

1. Donohoe CL, RyanAM, Reynolds JV. Cancer cachexia: mechanisms and clinical implications. Gastroenterol Res Pract. 2011; 2011: 601434. doi: 10. 1155/2011/601434.
2. Toth MJ, Matthews DE. Whole-body protein metabolism in chronic heart failure: relationship to anabolic and catabolic hormones. JPEN J Parenter Enteral Nutr. 2006; 30: 194-201.
3. Poehlman ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med. 1994; 121: 860-2.
4. Toth MJ, Gottlieb SS, Fisher ML, Poehlman ET. Daily energy requirements in heart failure patients. Metabolism. 1997; 46: 1294-8.
5. Ortiz RM, Kobori H, Conte D, Navar LG. Angiotensin IIinduced reduction in body mass is Ang II receptor mediated in association with elevated corticosterone. Growth Horm IGF Res. 2010; 20: 282-8. doi: 10. 1016/j. ghir. 2010. 03. 003.
6. Amitani M, Asakawa A, Amitani H, Inui A. Control of food intake and muscle wasting in cachexia. Int J Biochem Cell Biol. 2013; 45: 2179-85. doi: 10. 1016/j. biocel. 2013. 07. 016.
7. Yoshida T, Galvez S, Tiwari S, Rezk BM, Semprun-Prieto L, Higashi Y, et al. Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration. J Biol Chem. 2013; 288: 23823-32.
8. Müller-Fielitz H, Markert A, Wittmershaus C, Pahlke F, Jöhren O, Raasch W. Weight loss and hypophagia after high-dose AT1-blockade is only observed after high dosing and depends on regular leptin signalling but not blood pressure. Naunyn Schmiedebergs Arch Pharmacol. 2011; 383: 373-84. doi: 10. 1007/s00210-011-0602-5.
9. BrinkM, Wellen J, Delafontaine P. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J Clin Invest. 1996; 97: 2509-16.
10. Brink M, Price SR, Chrast J, Bailey JL, Anwar A, Mitch WE, et al. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology. 2001; 142: 1489-96.
11. Porter JP, Anderson JM, Robison RJ, Phillips AC. Effect of central angiotensin II on body weight gain in young rats. Brain Res. 2003; 959: 20-8.
12. Song YH, Li Y, Du J, Mitch WE, Rosenthal N, Delafontaine P. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest. 2005; 115: 451-8.
13. Cassis LA, Marshall DE, Fettinger MJ, Rosenbluth B, Lodder RA. Mechanisms contributing to angiotensin II regulation of bodyweight. Am J Physiol. 1998; 274: E867-76.
14. English V, Cassis L. Facilitation of sympathetic neurotransmission contributes to angiotensin regulation of body weight. J Neural Transm. 1999; 106: 631-44.
15. Bing C, Russell ST, Beckett EE, Collins P, Taylor S, Barraclough R, et al. Expression of uncoupling proteins-1,-2 and-3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. Br J Cancer. 2002; 86: 612-8.
16. Bing C, Russell S, Becket E, PopeM, TisdaleMJ, Trayhurn P. Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice. Br J Cancer. 2006; 95: 1028-37.
17. Adams V, Anker SD, Schuler G. Muscle metabolism and exercise capacity in cachexia. Curr Pharm Des. 2011; 17: 3838-45.
18. Brink M, Price SR, Chrast J, Bailey JL, Anwar A, Mitch WE, et al. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology. 2001; 142: 1489-96.
19. Schulze PC, Späte U. Insulin-like growth factor-1 and muscle wasting in chronic heart failure. Int J Biochem Cell Biol. 2005; 37: 2023-35.
20. Bihoreau C, Monnot C, Davies E, Teutsch B, BernsteinKE, Corvol P, et al. Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. Proc Natl Acad Sci U S A. 1993; 90: 5133-7.
21. Cordopatis P, Manessi-Zoupa E, Theodoropoulos D, Bossé R, Bouley R, Gagnon S, et al. Methylation in positions 1 and 7 of angiotensin II. A structure-activity relationship study. Int J Pept Protein Res. 1994; 44: 320-4.
22. Porter JP, Potratz KR. Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats. Am J Physiol Regul Integr Comp Physiol. 2004; 287: R422-8.
23. Yoshida T, Semprun-Prieto L, Wainford RD, Sukhanov S, Kapusta DR, Delafontaine P. Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus. Endocrinology. 2012; 153: 1411-20. doi: 10. 1210/en. 2011-1764.
24. Yoshida T, Tabony AM, Galvez S, Mitch WE, Higashi Y, Sukhanov S, et al. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: Potential therapeutic targets for cardiac cachexia. Int J Biochem Cell Biol. 2013; 45: 2322-32. doi: 10. 1016/j. biocel. 2013. 05. 035.
25. Mirza KA, Tisdale MJ. Role of Ca2+ in proteolysis-inducing factor (PIF)-induced atrophy of skeletal muscle. Cell Signal. 2012; 24: 2118-22. doi: 10. 1016/j. cellsig. 2012. 07. 016.
26. Porter JP, Potratz KR. Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats. Am J Physiol Regul Integr Comp Physiol. 2004; 287: R422-8.
27. Poehlman ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med. 1994; 121: 860-2.
28. Huentelman MJ, Grobe JL, Vazquez J, Stewart JM, Mecca AP, Katovich MJ, et al. Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. Exp Physiol. 2005; 90: 783-90.
29. Bing C, Brown M, King P, Collins P, Tisdale MJ, Williams G. Increased gene expression of brown fat uncoupling protein (UCP)1 and skeletal muscle UCP2 and UCP3 in MAC16-induced cancer cachexia. Cancer Res. 2000; 60: 2405-10.
30. Busquets S, Almendro V, Barreiro E, FiguerasM, Argilés JM, López-Soriano FJ. Activation of UCPs gene expression in skeletal muscle can be independent on both circulating fatty acids and food intake. Involvement of ROS in a model of mouse cancer cachexia. FEBS Lett. 2005; 579: 717-22.
31. TrobecK, von Haehling S, Anker SD, LainscakM. Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia. J Cachexia Sarcopenia Muscle. 2011; 2: 191-200.
32. Sanders PM, Tisdale MJ. Role of lipid-mobilising factor (LMF) in protecting tumour cells from oxidative damage. Br J Cancer. 2004; 90: 1274-8.
33. Guo P, Nishiyama A, Rahman M, Nagai Y, Noma T, Namba T, et al. Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade. J Hypertens. 2006; 24: 1097-104.
34. Sukhanov S, Semprun-Prieto L, Yoshida T, Michael Tabony A, Higashi Y, Galvez S. Angiotensin II, oxidative stress and skeletal muscle wasting. Am J Med Sci. 2011; 342: 143-7. doi: 10. 1097/MAJ. 0b013e318222e620.
35. Russell ST, Eley H, Tisdale MJ. Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysisinducing factor and angiotensin II. Cell Signal. 2007; 19: 1797-806.
36. Ko SH, Choi SW, Ye SK, Yoo S, Kim HS, Chung MH. Comparison of anti-oxidant activities of seventy herbs that have been used in Korean traditional medicine. Nutr Res Pract. 2008; 2: 143-51. doi: 10. 4162/nrp. 2008. 2. 3. 143.
37. Zhang Z, Chang Q, Zhu M, Huang Y, Ho WK, Chen Z. Characterization of antioxidants present in hawthorn fruits. J Nutr Biochem. 2001; 12: 144-52.